Name: Surv.AI Says: Real-World Insights into the Journey for Patients with Pulmonary Arterial Hypertension
Start: 2024-05-21T18:30:00-07:00
End: 2024-05-21T21:30:00-07:00

May 2024

Industry Theater
May 21 @ 11:30 am – 12:00 pm PDT

Navigating the COPD Patient Journey With Nebulized Maintenance Therapy

Featured Industry Theater
May 21 @ 11:30 am – 12:15 pm PDT

Expectations for Oral Corticosteroid Use

Learn More

Industry Theater
May 21 @ 11:30 am – 12:30 pm PDT

The Importance of a Proactive Approach to the Management of COPD

Innovation Hub
May 21 @ 11:35 am – 11:55 am PDT

Postoperative Prolonged Air Leaks with the Spiration Valve System, Roy Cho, MD

Industry Theater
May 21 @ 11:45 am – 12:30 pm PDT

Building on Foundational Pathways: A New Treatment Option for PAH

Featured Industry Theater
May 21 @ 12:00 pm – 12:30 pm PDT

Holistic Care of the Immunocompromised Pulmonary Patient with EGPA

Learn More

Industry Theater
May 21 @ 12:30 pm – 1:00 pm PDT

Emerging Pathways to Precision Medicine for Alpha-1 Antitrypsin Deficiency

Innovation Hub
May 21 @ 12:35 pm – 12:55 pm PDT

The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on mucociliary dysfunction

Industry Theater
May 21 @ 1:00 pm – 1:45 pm PDT

Understanding EGPA and the Role of Eosinophilic Inflammation

Industry Theater
May 21 @ 1:00 pm – 2:00 pm PDT

Ignite New Thinking in COPD: Exploring Type 2 Inflammation

Industry Theater
May 21 @ 1:15 pm – 2:15 pm PDT

Global Health Inequities in Chronic Respiratory Disease: Challenges and Potential Solutions

Industry Theater
May 21 @ 1:30 pm – 2:15 pm PDT

Machine Learning and Fibrosing Lung Disease: Imaging Biomarker Progress – with Dr. Simon Walsh and Dr. Kevin Brown, moderated by Elizabeth Estes

Evening Symposium
May 21 @ 6:30 pm – 8:00 pm PDT

PATHWAYS in Type 2 Inflammation Global Grant Initiative

Evening Symposium
May 21 @ 6:30 pm – 9:30 pm PDT

Filters

May 2024